Share
09.11.2023

Call: InterAb 2023

Cad_Lin, the official publication for papers presented at the InterAb conference, invites authors to submit their work for consideration in our journal. If you presented a paper at InterAb 2023 and wish to publish it in Cad_Lin, please carefully review the following important information.

Submission Criteria:

  • Authors are required to indicate whether their conducted research was preregistered, with or without an analysis plan, in an independent, institutional registry such as ClinicalTrials.gov, AEA RCT Registry, OSF, EGAP Registry, RIDIE.
  • Research involving human subjects, human material, or human data must adhere to the principles of respect for persons, beneficence, and justice outlined in the Belmont Report. Authors must provide details of ethics committee approval, including the committee's name and reference number, where applicable.

Documentation and Accessibility:

  • Cad_Lin only publishes papers with clear and precise documentation of data, analysis methods, and research materials. These must be maximally available at a trusted digital repository (e.g., Zenodofigshare and OSF) for the purpose of result reproduction or procedure replication.
  • Authors must submit all materials supporting their claims to the journal before publication.

Standards and Compliance:

  • Authors are required to review relevant standards for research applications from the Equator Network. During manuscript submission, authors must confirm that they have reviewed and followed applicable standards for their research application.

Submission Process:

  • Cad_Lin supports initial submissions without mandatory formatting to expedite the manuscript preparation process. However, essential information is required. Optionally, authors may consider the formatting required for accepted works during the initial submission. Detailed guidelines are available on the Cad_Lin website.

Deadline:

  • The deadline for submitting articles presented at InterAb 2023 is January 31, 2024.

We look forward to receiving your submissions and appreciate your commitment to the highest standards of research and publication ethics.

More announcements